Low dimensional semiconductor quantum dots (<10 nm) have received great attention for potential use in biomedical applications (diagnosis and therapy) for which larger nanoparticles (>10 nm) are not suitable. Here, we demonstrate a green, biogenic synthesis route for making CdS quantum dots (QDs) with 2-5 nm particle size using tea leaf extract (Camellia sinensis) as a toxic-free particle stabilizing agent. We have explored the biological activity of these CdS QDs in different applications, namely; a) antibacterial activity b) bioimaging and c) apoptosis of lung cancer cells. The antibacterial activity of the CdS QDs has been studied against different types of bacteria growth, showing that CdS QDs effectively inhibit the bacterial growth and exhibit cytotoxicity towards A549 cancer cells when compared to a control (no QD treatment). We have compared this cytotoxicity effect on A549 cancer cells with a standard drug, cisplatin, showing comparable results. Additionally, these CdS QDs produce high contrast fluorescence images of A549 cancer cells indicating a strong interaction with the cancer cell. To further understand the role of CdS QDs in bioimaging and cytotoxicity effect in A549 cells, fluorescence emission and flow cytometry analysis were carried out. The fluorescence emission of CdS QDs were recorded with λexc= 410 nm, showing concentration dependence fluorescence emission centered at 670 nm. From the flow cytometry analysis, it is confirmed that the CdS QDs are arresting the A549 cell growth at the S phase of cell cycle, inhibiting further growth of lung cancer cell. The multifunctional advantages of Camellia sinensis extract mediated green CdS QDs will be of widespread interest in implementing in-vivo based bioimaging and therapeutic cancer treatment applications.

No abstract

Proanthocyanidin (PAC) is a promising compound that has displayed its potent antineoplastic properties with a specific intrinsic pathway. This precise us to explore the phyto-preventive effect of PAC against colon cancer (HT-29). The results showed that PAC inhibited the cell growth and GI 50 value was found to be 6.25 μM for 24 h exposure, when correlated to the normal cell line does not have toxicity was noticed. The linguistic differences, similarly membrane blebbing, cell shrinkage fragmented nuclear bodies and mitochondrial membrane were observed in AO/EtBr and DAPI staining. The features of regular mechanical apoptotic characterization was analyzed by DNA fragmentation. The cell cycle arrest at G2/M phases was detected using FACS analysis. The early and late apoptotic cells were observed by using Annexin V/PI staining. The ligand–protein interaction and docking studies were performed using Schrodinger’s software. The QPLD analysis of docking studies revealed that PAC exhibited better binding affinity of − 5.23, − 5.17 and − 4.43, − 4.47 kcal/mol against BCL-XL, CDK2 and were compared with 5-FU respectively, which significantly reveals the anticancerous activity of Proanthocyanidin compound. Thus, the PAC compound provides future application of therapeutic option in the treatment of colon cancers .

Tea is one of the most ancient popular beverages and extensively used dietary supplement in the western world. Tea leaves are rich in polyphenols and also well known for its antioxidant properties. In addition, green tea extract contains several polyphenols with antioxidant compounds. The predominant effective antioxidant components are epigallocatechin 3-gallate and epicatechin 3-gallate (monomers). Tea polyphenols have an additional role to induce aroma and taste in beverages. Furthermore, tea polyphenols have multiple applications in food industry and biomedical applications. This chapter will summarise the origin of tea leaves and its beneficial account on antioxidant, food industry (meat products, plant products and fish products) and therapeutic applications against many diseases such as lowering of blood pressure, diabetes, Parkinson's disease and anticancer properties. Mainly tea polyphenols have potential to inhibit the cancer proliferation of skin, prostate, lung and breast cancer.

The present study reports the validation of cancer nanotherapy using proanthocyanidin (PAC). Nowadays, in vitro and in vivo deliveries of nanoparticle (NPs) drugs have been paid more attention, intensively. Moreover, the current chemotherapeutic drugs have few first rate drawbacks including lack of specificity and requirement of excessive drug doses. To overcome this problem of chemotherapy, the attainment of high drug loading in combination with degradable polymer nanoparticles (for instance,chitosan) is a trending research in cancer biology. Hence, in this study, the synthesized PAC-AgNPs were successfully crosslinked with chitosan nanoparticles (CS-PAC-AgNPs), which were found to be spherical or polygonal in shape with a median size of 70.68 nm and 52.16 nm as observed by FTIR, FESEM and TEM analysis; thus, being suitable for drug delivery. CS-PAC-AgNPs were taken up via endocytosis by cancer cells and enabled the release cytochrome-C from mitochondria, followed by dysregulation of anti-apoptotic protein Bcl2 family, inducing the apoptotic mediated activation of caspase 9 and 3. To identify the genotoxicity of the synthesized CS-PAC-AgNPs, the mortality, hatching rate, malformation and abnormalities of embryo/larvae of the vertebrate zebra fish model ( Danio rerio ) were observed in a dose-time-dependent manner. This improved cancer nanotherapy can thus be utilized as a novel nanocombination for inducing apoptosis in vitro and in vivo .

No abstract

No abstract

No abstract